Loading…
Extrasynaptic GABAA Receptors: Form, Pharmacology, and Function
GABA is the principal inhibitory neurotransmitter in the CNS and acts via GABA(A) and GABA(B) receptors. Recently, a novel form of GABA(A) receptor-mediated inhibition, termed "tonic" inhibition, has been described. Whereas synaptic GABA(A) receptors underlie classical "phasic" G...
Saved in:
Published in: | The Journal of neuroscience 2009-10, Vol.29 (41), p.12757-12763 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 12763 |
container_issue | 41 |
container_start_page | 12757 |
container_title | The Journal of neuroscience |
container_volume | 29 |
creator | Belelli, Delia Harrison, Neil L Maguire, Jamie Macdonald, Robert L Walker, Matthew C Cope, David W |
description | GABA is the principal inhibitory neurotransmitter in the CNS and acts via GABA(A) and GABA(B) receptors. Recently, a novel form of GABA(A) receptor-mediated inhibition, termed "tonic" inhibition, has been described. Whereas synaptic GABA(A) receptors underlie classical "phasic" GABA(A) receptor-mediated inhibition (inhibitory postsynaptic currents), tonic GABA(A) receptor-mediated inhibition results from the activation of extrasynaptic receptors by low concentrations of ambient GABA. Extrasynaptic GABA(A) receptors are composed of receptor subunits that convey biophysical properties ideally suited to the generation of persistent inhibition and are pharmacologically and functionally distinct from their synaptic counterparts. This mini-symposium review highlights ongoing work examining the properties of recombinant and native extrasynaptic GABA(A) receptors and their preferential targeting by endogenous and clinically relevant agents. In addition, it emphasizes the important role of extrasynaptic GABA(A) receptors in GABAergic inhibition throughout the CNS and identifies them as a major player in both physiological and pathophysiological processes. |
doi_str_mv | 10.1523/JNEUROSCI.3340-09.2009 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2784229</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67694023</sourcerecordid><originalsourceid>FETCH-LOGICAL-h212t-69a468f7c71775a862481a32e025ea52ad5985a68a70bc4ac3caa8f8542a6e7e3</originalsourceid><addsrcrecordid>eNpVkMtOwzAQRS0EgvL4BZQVYkGKPXH8YAEqVQtFiCIea2vquk1QEpc4pfTviURBsJrFPTr3agg5ZrTLUkjO7x4Gr0_j5_6omyScxlR3gVK9RTptqmPglG2TDgVJY8El3yP7IbxRSiVlcpfsMa1ASSU65Grw2dQY1hUumtxGN73rXi96ctYtGl-Hi2jo6_IsesywLtH6ws_XZxFW02i4rGyT--qQ7MywCO5ocw_I63Dw0r-N78c3o37vPs6AQRMLjVyombSSSZmiEsAVwwQchdRhCjhNtUpRKJR0YjnaxCKqmUo5oHDSJQfk8tu7WE5KN7WuamcXZlHnJdZr4zE3_5Mqz8zcfxiQigPoVnCyEdT-felCY8o8WFcUWDm_DEZIoTmFpAWP_zb9Vvz8rAVOv4Esn2ervHYmlFgULc7MarUCbTgzDGQqky_0TX24</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67694023</pqid></control><display><type>article</type><title>Extrasynaptic GABAA Receptors: Form, Pharmacology, and Function</title><source>PubMed (Medline)</source><creator>Belelli, Delia ; Harrison, Neil L ; Maguire, Jamie ; Macdonald, Robert L ; Walker, Matthew C ; Cope, David W</creator><creatorcontrib>Belelli, Delia ; Harrison, Neil L ; Maguire, Jamie ; Macdonald, Robert L ; Walker, Matthew C ; Cope, David W</creatorcontrib><description>GABA is the principal inhibitory neurotransmitter in the CNS and acts via GABA(A) and GABA(B) receptors. Recently, a novel form of GABA(A) receptor-mediated inhibition, termed "tonic" inhibition, has been described. Whereas synaptic GABA(A) receptors underlie classical "phasic" GABA(A) receptor-mediated inhibition (inhibitory postsynaptic currents), tonic GABA(A) receptor-mediated inhibition results from the activation of extrasynaptic receptors by low concentrations of ambient GABA. Extrasynaptic GABA(A) receptors are composed of receptor subunits that convey biophysical properties ideally suited to the generation of persistent inhibition and are pharmacologically and functionally distinct from their synaptic counterparts. This mini-symposium review highlights ongoing work examining the properties of recombinant and native extrasynaptic GABA(A) receptors and their preferential targeting by endogenous and clinically relevant agents. In addition, it emphasizes the important role of extrasynaptic GABA(A) receptors in GABAergic inhibition throughout the CNS and identifies them as a major player in both physiological and pathophysiological processes.</description><identifier>ISSN: 0270-6474</identifier><identifier>EISSN: 1529-2401</identifier><identifier>DOI: 10.1523/JNEUROSCI.3340-09.2009</identifier><identifier>PMID: 19828786</identifier><language>eng</language><publisher>United States: Soc Neuroscience</publisher><subject>Animals ; Biophysical Phenomena - drug effects ; Biophysical Phenomena - physiology ; Central Nervous System - drug effects ; Central Nervous System - physiology ; Female ; gamma-Aminobutyric Acid - metabolism ; gamma-Aminobutyric Acid - pharmacology ; Humans ; Male ; Neural Inhibition - drug effects ; Neural Inhibition - physiology ; Pregnancy ; Presynaptic Terminals - drug effects ; Presynaptic Terminals - metabolism ; Protein Subunits - physiology ; Receptors, GABA-A - physiology ; Symposia and Mini-Symposia ; Synaptic Transmission - drug effects ; Synaptic Transmission - physiology</subject><ispartof>The Journal of neuroscience, 2009-10, Vol.29 (41), p.12757-12763</ispartof><rights>Copyright © 2009 Society for Neuroscience 0270-6474/09/2912757-07$15.00/0 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784229/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784229/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19828786$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Belelli, Delia</creatorcontrib><creatorcontrib>Harrison, Neil L</creatorcontrib><creatorcontrib>Maguire, Jamie</creatorcontrib><creatorcontrib>Macdonald, Robert L</creatorcontrib><creatorcontrib>Walker, Matthew C</creatorcontrib><creatorcontrib>Cope, David W</creatorcontrib><title>Extrasynaptic GABAA Receptors: Form, Pharmacology, and Function</title><title>The Journal of neuroscience</title><addtitle>J Neurosci</addtitle><description>GABA is the principal inhibitory neurotransmitter in the CNS and acts via GABA(A) and GABA(B) receptors. Recently, a novel form of GABA(A) receptor-mediated inhibition, termed "tonic" inhibition, has been described. Whereas synaptic GABA(A) receptors underlie classical "phasic" GABA(A) receptor-mediated inhibition (inhibitory postsynaptic currents), tonic GABA(A) receptor-mediated inhibition results from the activation of extrasynaptic receptors by low concentrations of ambient GABA. Extrasynaptic GABA(A) receptors are composed of receptor subunits that convey biophysical properties ideally suited to the generation of persistent inhibition and are pharmacologically and functionally distinct from their synaptic counterparts. This mini-symposium review highlights ongoing work examining the properties of recombinant and native extrasynaptic GABA(A) receptors and their preferential targeting by endogenous and clinically relevant agents. In addition, it emphasizes the important role of extrasynaptic GABA(A) receptors in GABAergic inhibition throughout the CNS and identifies them as a major player in both physiological and pathophysiological processes.</description><subject>Animals</subject><subject>Biophysical Phenomena - drug effects</subject><subject>Biophysical Phenomena - physiology</subject><subject>Central Nervous System - drug effects</subject><subject>Central Nervous System - physiology</subject><subject>Female</subject><subject>gamma-Aminobutyric Acid - metabolism</subject><subject>gamma-Aminobutyric Acid - pharmacology</subject><subject>Humans</subject><subject>Male</subject><subject>Neural Inhibition - drug effects</subject><subject>Neural Inhibition - physiology</subject><subject>Pregnancy</subject><subject>Presynaptic Terminals - drug effects</subject><subject>Presynaptic Terminals - metabolism</subject><subject>Protein Subunits - physiology</subject><subject>Receptors, GABA-A - physiology</subject><subject>Symposia and Mini-Symposia</subject><subject>Synaptic Transmission - drug effects</subject><subject>Synaptic Transmission - physiology</subject><issn>0270-6474</issn><issn>1529-2401</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNpVkMtOwzAQRS0EgvL4BZQVYkGKPXH8YAEqVQtFiCIea2vquk1QEpc4pfTviURBsJrFPTr3agg5ZrTLUkjO7x4Gr0_j5_6omyScxlR3gVK9RTptqmPglG2TDgVJY8El3yP7IbxRSiVlcpfsMa1ASSU65Grw2dQY1hUumtxGN73rXi96ctYtGl-Hi2jo6_IsesywLtH6ws_XZxFW02i4rGyT--qQ7MywCO5ocw_I63Dw0r-N78c3o37vPs6AQRMLjVyombSSSZmiEsAVwwQchdRhCjhNtUpRKJR0YjnaxCKqmUo5oHDSJQfk8tu7WE5KN7WuamcXZlHnJdZr4zE3_5Mqz8zcfxiQigPoVnCyEdT-felCY8o8WFcUWDm_DEZIoTmFpAWP_zb9Vvz8rAVOv4Esn2ervHYmlFgULc7MarUCbTgzDGQqky_0TX24</recordid><startdate>20091014</startdate><enddate>20091014</enddate><creator>Belelli, Delia</creator><creator>Harrison, Neil L</creator><creator>Maguire, Jamie</creator><creator>Macdonald, Robert L</creator><creator>Walker, Matthew C</creator><creator>Cope, David W</creator><general>Soc Neuroscience</general><general>Society for Neuroscience</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20091014</creationdate><title>Extrasynaptic GABAA Receptors: Form, Pharmacology, and Function</title><author>Belelli, Delia ; Harrison, Neil L ; Maguire, Jamie ; Macdonald, Robert L ; Walker, Matthew C ; Cope, David W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h212t-69a468f7c71775a862481a32e025ea52ad5985a68a70bc4ac3caa8f8542a6e7e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Animals</topic><topic>Biophysical Phenomena - drug effects</topic><topic>Biophysical Phenomena - physiology</topic><topic>Central Nervous System - drug effects</topic><topic>Central Nervous System - physiology</topic><topic>Female</topic><topic>gamma-Aminobutyric Acid - metabolism</topic><topic>gamma-Aminobutyric Acid - pharmacology</topic><topic>Humans</topic><topic>Male</topic><topic>Neural Inhibition - drug effects</topic><topic>Neural Inhibition - physiology</topic><topic>Pregnancy</topic><topic>Presynaptic Terminals - drug effects</topic><topic>Presynaptic Terminals - metabolism</topic><topic>Protein Subunits - physiology</topic><topic>Receptors, GABA-A - physiology</topic><topic>Symposia and Mini-Symposia</topic><topic>Synaptic Transmission - drug effects</topic><topic>Synaptic Transmission - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Belelli, Delia</creatorcontrib><creatorcontrib>Harrison, Neil L</creatorcontrib><creatorcontrib>Maguire, Jamie</creatorcontrib><creatorcontrib>Macdonald, Robert L</creatorcontrib><creatorcontrib>Walker, Matthew C</creatorcontrib><creatorcontrib>Cope, David W</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Belelli, Delia</au><au>Harrison, Neil L</au><au>Maguire, Jamie</au><au>Macdonald, Robert L</au><au>Walker, Matthew C</au><au>Cope, David W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Extrasynaptic GABAA Receptors: Form, Pharmacology, and Function</atitle><jtitle>The Journal of neuroscience</jtitle><addtitle>J Neurosci</addtitle><date>2009-10-14</date><risdate>2009</risdate><volume>29</volume><issue>41</issue><spage>12757</spage><epage>12763</epage><pages>12757-12763</pages><issn>0270-6474</issn><eissn>1529-2401</eissn><abstract>GABA is the principal inhibitory neurotransmitter in the CNS and acts via GABA(A) and GABA(B) receptors. Recently, a novel form of GABA(A) receptor-mediated inhibition, termed "tonic" inhibition, has been described. Whereas synaptic GABA(A) receptors underlie classical "phasic" GABA(A) receptor-mediated inhibition (inhibitory postsynaptic currents), tonic GABA(A) receptor-mediated inhibition results from the activation of extrasynaptic receptors by low concentrations of ambient GABA. Extrasynaptic GABA(A) receptors are composed of receptor subunits that convey biophysical properties ideally suited to the generation of persistent inhibition and are pharmacologically and functionally distinct from their synaptic counterparts. This mini-symposium review highlights ongoing work examining the properties of recombinant and native extrasynaptic GABA(A) receptors and their preferential targeting by endogenous and clinically relevant agents. In addition, it emphasizes the important role of extrasynaptic GABA(A) receptors in GABAergic inhibition throughout the CNS and identifies them as a major player in both physiological and pathophysiological processes.</abstract><cop>United States</cop><pub>Soc Neuroscience</pub><pmid>19828786</pmid><doi>10.1523/JNEUROSCI.3340-09.2009</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0270-6474 |
ispartof | The Journal of neuroscience, 2009-10, Vol.29 (41), p.12757-12763 |
issn | 0270-6474 1529-2401 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2784229 |
source | PubMed (Medline) |
subjects | Animals Biophysical Phenomena - drug effects Biophysical Phenomena - physiology Central Nervous System - drug effects Central Nervous System - physiology Female gamma-Aminobutyric Acid - metabolism gamma-Aminobutyric Acid - pharmacology Humans Male Neural Inhibition - drug effects Neural Inhibition - physiology Pregnancy Presynaptic Terminals - drug effects Presynaptic Terminals - metabolism Protein Subunits - physiology Receptors, GABA-A - physiology Symposia and Mini-Symposia Synaptic Transmission - drug effects Synaptic Transmission - physiology |
title | Extrasynaptic GABAA Receptors: Form, Pharmacology, and Function |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T04%3A42%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Extrasynaptic%20GABAA%20Receptors:%20Form,%20Pharmacology,%20and%20Function&rft.jtitle=The%20Journal%20of%20neuroscience&rft.au=Belelli,%20Delia&rft.date=2009-10-14&rft.volume=29&rft.issue=41&rft.spage=12757&rft.epage=12763&rft.pages=12757-12763&rft.issn=0270-6474&rft.eissn=1529-2401&rft_id=info:doi/10.1523/JNEUROSCI.3340-09.2009&rft_dat=%3Cproquest_pubme%3E67694023%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-h212t-69a468f7c71775a862481a32e025ea52ad5985a68a70bc4ac3caa8f8542a6e7e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=67694023&rft_id=info:pmid/19828786&rfr_iscdi=true |